Get App
Download App Scanner
Scan to Download
Advertisement

Fine Organic, Jubilant Ingrevia Top Anand Rathi's List In Chemical Pack — Check Target Price

Anand Rathi remains bullish on Jubilant Ingrevia, Fine Organic — check potential upside and more

Fine Organic, Jubilant Ingrevia Top Anand Rathi's List In Chemical Pack — Check Target Price
The chemical companies in Anand Rathi's coverage universe reported revenue/Ebitda growth of 14/18% YoY in Q3 FY26.
(Photo: Freepik)
STOCKS IN THIS STORY
Jubilant Ingrevia Ltd
--
Fine Organic Industries Ltd.
--
Deepak Nitrite Ltd.
--
Laxmi Organic Industries Ltd
--
Galaxy Surfactants Ltd.
--
Navin Fluorine International Ltd.
--
Neogen Chemicals Ltd.
--
Nocil Ltd.
--
PI Industries Ltd.
--
Rossari Biotech Ltd.
--
SRF Ltd.
--
Sudarshan Chemical Industries Ltd.
--
Tata Chemicals Ltd.
--
Vinati Organics Ltd.
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Anand Rathi Report

Top Picks

Fine Organic Industries

Fine Organic is undergoing a significant capacity expansion with the India SEZ (JNPT) and US Phase-I projects set to commercialise 18-24 months post the Apr-25 EC, unlocking saturated domestic sites for higher-value products.

The SEZ land parcel exceeds all existing sites combined, while the US parcel is five times larger, providing long-term scale visibility. With US approvals in place, Phase-I is de-risked, paving the way for a faster Phase-II. Global validations support onboarding larger customers and deeper wallet share.

The US, ~26% of global additives market (vs India's <4%), offers a strong localisation opportunity given strict manufacturing date norms limiting ocean freight viability.

Despite near-term utilisation constraints, end-FY27/early-FY28 capacity addition underpins a multi-year growth runway.

Expansion is largely self-funded, supported by ~Rs 1,300 crore cash and ~Rs 900 crore expected FY26-27 cash generation (with project debt as needed).

At 28/24x FY27/28e EPS trough multiples, the brokerage maintain Buy rating on the stock with a 12-month target price of Rs 6,400, valuing it at 34x FY28e EPS.

Key Risks: US execution; SEZ timelines; and input volatility.

Click on the attachment to read the full report:

Anand Rathi Chemical Sector Report.pdf
VIEW DOCUMENT

ALSO READ: 'Buy' Polycab Shares Maintains Motilal Oswal On Multiple Growth Triggers — Check Target Price

ALSO READ: Coforge Set For 100% Upside? Centrum Has A Strong Buy Rating On IT Firm

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search